-The Times of India MENDHARI (GADCHIROLI): The picturesque little hamlet of Mendhari, around 90-km from Gadchiroli town, was considered by the Naxalites as a safe haven. The tranquillity here had remained undisputed until Sunday when, for the first time, the villagers witnessed a lopsided bloodbath in which six women rebels were killed in police firing. The villagers, who claimed to have been thrashed by the C-60 commandos too, told TOI that four...

-The Telegraph The proliferation and sales of anti-diabetes combination pills that contain two drugs to control Blood Sugar has stirred concerns in medical circles that a large proportion of diabetes patients in India are not receiving ideal treatment. A study by Indian and British researchers has shown that such two-drug combo pills accounted for more than half of the sales of all oral anti-diabetes medications in India last year, although doctors say...

-The Hindu     Hema Vijay meets R. Rajamurugan who's on a quest to document and rejuvenate forgotten food traditions of the State Chennai: This young man visits obscure villages, speaking to farmers in the fields and elderly village women, sifting through folklore and oral history on food. R. Rajamurugan's grand vision is to document and rejuvenate ancient and forgotten food traditions of the State. "For instance, consider ‘Kongu Nadu' that includes regions such...

-The Hindu Chronic corruption and lack of affordable access to treatments for serious diseases in the public health system stand exposed in the kidney commerce scandal in Tamil Nadu's Dharmapuri district. Nothing can be a greater irony than the existence of such thriving sale of organs in a State that also has perhaps the best-run programme for donation of kidneys, livers, hearts and lungs by deceased donors. It is no small...

-The Business Standard The tussle between the US Food and Drug Administration (US FDA) and Ranbaxy is likely to hit the plans of Indian pharmaceutical companies of making it big in the US generic drugs market. Apart from the fact that their image may take a beating, the additional scrutiny on abbreviated new drug applications (ANDAs) from India would lead to more delays in drug approvals. Last week, Ranbaxy had agreed to...